Rajappa, R., Sireesh, D., Salai, M. B., Ramkumar, K. M., Sarvajayakesavulu, S., & Madhunapantula, S. V. (2019). Treatment With Naringenin Elevates the Activity of Transcription Factor Nrf2 to Protect Pancreatic β-Cells From Streptozotocin-Induced Diabetes in vitro and in vivo. Front Pharmacol.

Rajappa, Rashmi, Dornadula Sireesh, Magesh B. Salai, Kunka M. Ramkumar, Suryanarayanan Sarvajayakesavulu, and SubbaRao V. Madhunapantula. "Treatment With Naringenin Elevates the Activity of Transcription Factor Nrf2 to Protect Pancreatic β-Cells From Streptozotocin-Induced Diabetes in Vitro and in Vivo." Front Pharmacol 2019.

Rajappa, Rashmi, et al. "Treatment With Naringenin Elevates the Activity of Transcription Factor Nrf2 to Protect Pancreatic β-Cells From Streptozotocin-Induced Diabetes in Vitro and in Vivo." Front Pharmacol 2019.